Putative Cellular and Molecular Roles of Zika Virus in Fetal and Pediatric Neuropathologies by Ghardbaran, Rajendra et al.
City University of New York (CUNY) 
CUNY Academic Works 
Publications and Research Bronx Community College 
2019 
Putative Cellular and Molecular Roles of Zika Virus in Fetal and 
Pediatric Neuropathologies 
Rajendra Ghardbaran 
CUNY Bronx Community College 
Rajendra Ghardbaran 
CUNY Bronx Community College 
Latchman Somenarain 
How does access to this work benefit you? Let us know! 
More information about this work at: https://academicworks.cuny.edu/bx_pubs/71 
Discover additional works at: https://academicworks.cuny.edu 
This work is made publicly available by the City University of New York (CUNY). 
Contact: AcademicWorks@cuny.edu 
Review Article
Putative Cellular and Molecular
Roles of Zika Virus in Fetal and
Pediatric Neuropathologies
Rajendra Gharbaran1 and Latchman Somenarain1
Abstract
Although the World Health Organization declared an end to the recent Zika virus (ZIKV) outbreak and its association with
adverse fetal and pediatric outcome, on November 18, 2016, the virus still remains a severe public health threat. Laboratory
experiments thus far supported the suspicions that ZIKV is a teratogenic agent. Evidence indicated that ZIKV infection
cripples the host cells’ innate immune responses, allowing productive replication and potential dissemination of the virus. In
addition, studies suggest potential transplacental passage of the virus and subsequent selective targeting of neural progenitor
cells (NPCs). Depletion of NPCs by ZIKV is associated with restricted brain growth. And while microcephaly can result from
infection at any gestational stages, the risk is greater during the first trimester. Although a number of recent studies revealed
some of specific molecular and cellular roles of ZIKV proteins of this mosquito-borne flavivirus, the mechanisms by which it
produces it suspected pathophysiological effects are not completely understood. Thus, this review highlights the cellular and
molecular evidence that implicate ZIKV in fetal and pediatric neuropathologies.
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Introduction
The Zika virus (ZIKV), a positive-stranded RNA arbo-
virus that belongs to the genus Flavivirus and the family
Flaviviridae, was initially identified in Uganda in 1947.1
ZIKV historically was a benign human pathological
agent,2–4 producing only mild symptoms, which included
headache, malaise, fever, cutaneous rash, arthralgia (joint
pain), and conjunctivitis in about 20% of patients and
with 80% of infections being asymptomatic.5 However,
the recent upsurge in ZIKV infection and its association
with severe fetal and congenital neurological disorders in
South America (mainly Brazil) in 2015–2016 prompted
the World Health Organization to declare the situation,
a Public Health Emergency of International Concern.6
Similar outbreaks and associated outcome occurred in
the Pacific islands (specifically the island of Yap) in
20075 and in French Polynesia in 2012–2014.7 The virus
is transmitted predominantly by infected Aedes mosqui-
toes (A. aegypti, A. albopictus, A. africanus, and A. luteo-
cephalus)8 and to a lesser extent by sexual contact,9 the
prenatal route from mother to fetus,10 and through blood
transfusion.11
The epidemiological associations between ZIKV and
congenital neuropathologies have now been confirmed by
laboratory studies. The placenta and the fetal brain
appear to be 2 of the primary targets of ZIKV, leading
to fetal and congenital neurological anomalies. ZIKV
particles and proteins have been detected in human pla-
cental and fetal brain remnants.12 Experimental studies
showed that ZIKV infects, among other cells, placental
cells and neural stem cells where the virus also replicates
productively.13,14 Studies in mice suspected transplacental
ZIKV passage, resulting in restricted brain growth,15 sup-
posedly a consequence of depletion of neural progenitor
cells (NPCs).15,16 ZIKV-induced restricted brain growth
in mice recapitulates the features of congenital ZIKV-
associated microcephaly in humans.17 Other neonatal
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and pediatric neural disorders associated with ZIKV
infection include chorioretinopathy, sensory neural hear-
ing loss, and epilepsy and other motor deficits. This
review discusses the putative cellular and molecular
mechanism(s) of ZIKV in human fetal and pediatric
neuropathologies.
Brief Insights Into the Molecular
Biology of ZIKV
First discovered about 70 years ago in Uganda, ZIKV
maintained a low-profile agent of human pathology.
However, the recent outbreaks of ZIKV and its asso-
ciated devastating effects, in previously unsuspecting
and unaffected regions, first Oceana and subsequently
the Americas, prompted an astronomic rise in research
focus on infection by this flavivirus. The enhanced patho-
genicity of ZIKV may be due to genetic changes under-
gone by the virus, resulting in increased aggression
characterized by increased transmissibility and infectivity,
exaggerated neurotropic potential, and greater replicative
capability. Of particular concern is the ability of the virus
to breach the placental protection and trigger permanent
fetal brain injuries.
The ZIKV virion consists of an icosahedral shell
enclosing a positive strand RNA of 10,794 kb.18–20 The
genome undergoes translation to produce a single poly-
protein (of 3149 amino acids, aa), which is subsequently
cleaved to form 3 structural proteins—C (capsid) 105 aa,
PrM/M (precursor membrane) of 187 aa, the envelope
(E) of 505 aa—and 7 nonstructural proteins—NS1 (352
aa), NS2A (217aa), NS2B (139 aa), NS3 (619 aa), NS4A
(127 aa), NS4B (255 aa), and NS5 (904 aa)—by viral and
host proteases.18–20 The C protein interacts with the viral
RNA to form the nucleocaspid, and PrM is important to
prevent premature fusion of the virus with host cell mem-
branes.21,22 The E protein, which makes up the majority
of the virion surface and which is the antigenic site for
flaviviruses, facilitates membrane attachment and
increases membrane fusion and release of viral genome
into host.23 In flaviviruses, NS1, NS3, and NS5 are large,
highly conserved proteins, whereas NS2A, NS2B, NS4A,
and NS4B proteins are small, hydrophobic proteins.24
The NS2B and NS3 proteins are important for protein
synthesis and replication of viral genetic material.18,19
NS5 protein is the most conserved nonstructural protein
among flaviviruses and functions as an RNA-directed
RNA polymerase.18,25,26
Phylogenetic studies were carried out to determine the
evolution of ZIKV.27 An African lineage and an Asian
lineage were detected.27,28 However, the contemporary
strain was more related to the Asian lineage.27,28
Human strains identified in the 2015–2016 epidemic are
closely related to the French Polynesia/2013 than the
Micronesia/2007 strain, indicating a common ancestral
origin.27 The prM protein showed the highest percentage
variation between Asian and African subtypes, and mod-
eling analyses indicated that some of this variability
might contribute to significant structural changes.27
Yokoyama and Starmer also identified a number of
mutations in the Asian and American ZIKV, and they
speculated that these changes are likely to inhibit cellular
antiviral activities, including immune and RNA interfer-
ence pathways.29
An analysis of predicted epitopes and human antigens
indicated putative peptide sharing between ZIKV poly-
protein and human proteins which are associated with
neuropathologies, including microcephaly and brain cal-
cification.30 Such proteins include centriolar and centro-
somal components that are deregulated or mutated in
microcephaly, that is, C2CD3, CASC5, CP131, GCP4,
KIF2A, STIL, and TBG.30
The genetic similarity of ZIKV to another member of
the Flaviviridae, the dengue virus (DENV), which is also
known to trigger serious pathologies in humans, may also
account for its (ZIKV) cryptic pathogenicity. ZIKV is
associated with the 4 serotypes of DENV with approxi-
mately 43% amino acid sequence similarity.31 Studies
showed that antibodies isolated from DENV patients
potently neutralize ZIKV through targeting a conform-
ational epitope.32,33 However, it is suspected that some
ZIKV patients with a prior infection with DENV may
have a worst outcome, by a mechanism known as anti-
body-dependent enhancement.34 In vitro studies showed
that DENV-immune sera and DENV-specific monoclo-
nal antibodies cross-react with ZIKV and enhance its
infectious ability via FcRs,35 although the in vivo rele-
vance of this study remains elusive. FcRs are expressed
by a number of immune effector cells as well as by vari-
ous cell types of the placenta and the central nervous
system (CNS).
Mechanism(s) of Neurocellular Invasion
The mode of cellular infection by ZIKV is a matter of
controversy. Studies showed that putative ZIKV entry
receptors include DC-SIGN (dendritic cell-specific intra-
cellular adhesion molecule-3-grabbing nonintegrin)
receptor, heat shock protein, and tyrosine-kinase recep-
tors TIM (TIM-1, TIM-4) and TAM (Tyro3, Axl, and
Mer)36–38 (Figure 1). TAM receptors belong to a family
of tyrosine kinase receptors which are important in the
regulation of immune responses,39 including mediating
the physiologies of microglia,40 the brain’s immune
cells. TAM receptors maintain neurogenesis in adult
brain,41 and they are important for survival, prolifer-
ation, and differentiation of neural stem cells.42
Although TAM receptors are not critical for early embry-
onic brain development, they are expressed by cortical
NPCs during embryogenesis,43 as well as in NPCs derived
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from pluripotent stem cells (PSCs),14 making them prime
targets for ZIKV. Of the TAM receptors, AXL, a
member of the phosphatidylserine phagocytic protein
receptors, appears to be a principal receptor exploited
by ZIKV, although the virus may use a combination of
different receptors to gain cellular entry.44 Growth arrest-
specific protein 6 (GAS-6), found in blood and other
body fluids, is a natural ligand for AXL and other
TAM receptors.45 GAS-6 binds AXL at one end and
the membrane of ZIKV on the other, thereby mediating
viral entry into the host cells (Figure 1).46 Although GAS-
6 protein enhances the survival of oligodendrocytes and
neurons,47–50 there is no report of soluble GAS-6 in
human fetal cerebrospinal fluid (CSF). However, chronic
inflammatory conditions in the CNS are associated with
GAS-6 levels in CSF.51 In rats, GAS-6 is widely expressed
in the CNS in almost all stages of development, although
its precise role remains uncertain.52 GAS6-mediated
endocytosis of ZIKV may warrant a study that correlates
the levels of GAS-6 in body fluids and outcomes from
ZIKV infection. The expectation is that higher levels of
serum GAS-6 will result in worst prognosis in ZIKV
infection. Deregulated expression of GAS-6 and
increased serum levels of these proteins are negative prog-
nostic factors in a number of human malignancies.53,54
Studies indicated that ZIKV may invade host cells by
TAM receptor-independent mechanism(s). Genetic abla-
tion of AXL failed to protect NPCs and cerebral
organoid against ZIKV infection.55 ZIKV infection of
retinal cells of Axl/ knockout mice and ZIKV RNA
levels in the brains of infected Axl/ mice were compar-
able to that of wild-type animals.56 In addition, induced
pluripotent stem cells (iPSCs) resistant to ZIKV infection
express high levels of TYRO3 messenger RNA
(mRNA).55 Results from these studies indicated that
ZIKV may also invade cells via an AXL/TYRO3-inde-
pendent mechanism(s) or via other unidentified receptors.
A study in TAM (Tyro3, Axl, and Mer)-deficient mice
exposed to ZIKV showed no difference in infection when
compared to wild-type animals,57 supporting a TAM-
independent tropic mechanism for this flavivirus. A
receptor-independent mechanism may involve secreted
exosomes and extracellular vesicles (ECVs). Exosomes
are membrane-bound nanosized (30–100 nm) vesicles
that appear to be secreted by almost all cell types.
Exosomes and ECVs shuttle their cargo, which may
include lipids, proteins, and nucleic acids, and other regu-
latory elements between host cells and target cells.
Exosomes and ECVs may modulate cellular responses
of target cells by paracrine fashion or through systemic
circulation. Studies on viruses showed that exosomes
derived from infected cells are involved in spreading
infection to adjacent cells.58–61 Finally, another recep-
tor-independent mechanism of ZIKV infection may be
related to tunneling nanotubes (TNTs) used for intercel-
lular communication. Studies showed that viruses can be
shuttled between neighboring cells via TNTs,62,63 thereby
assisting in immune escape although this has not been
demonstrated for flaviviruses as yet. However, it is
unclear whether ZIKV exploits similar mechanisms in
the absence of TAM receptors on target cells. It is also
possible that dissemination of ZIKV occurs by a combin-
ation of these mechanisms.
Induction and Suppression of Cellular
Defenses/Innate Immune Pathways
The pathogenicity of ZIKV may be due to its ability to
induce and subsequently suppress cellular innate immune
responses. Infection by ZIKV resulted in increased
expression of type1 IFN-stimulated genes via TLR3
activation37 and the activation of pattern recognition
receptors. IFN-stimulated gene IFITM3, a small mem-
brane-associated IFN-inducible transmembrane protein
3, was shown to reduce the replication of flaviviruses.64
Savidis et al. showed that IFITM3 and IFITM1 inhibited
the replication of ZIKV.65 Of interest to the CNS, ZIKV
infection of human astrocytes resulted in decreased
IFITM3 levels, which is associated with increased cyto-
plasmic vacuoles derived from the endoplasmic reticulum
(ER), an indication of para-apoptotic cell death.66 In
addition, type III IFN, IFNl1 that are constitutively
secreted by placental trophoblasts, protected these cells
Figure 1. Putative receptor-mediated ZIKV infections and con-
sequences on brain circumference. ZIKV preferentially targets
neural cells that express AXL. Upon infection, ZIKV triggers cell
death by apoptosis necrosis and autophagy and also reduces pro-
liferation and differentiation of NPCs. Reduced NPCs resulted in
decreased head circumference typical of microcephaly.
DC-SIGN, dendritic cell-specific intracellular adhesion molecule-
3-grabbing nonintegrin; GAS6: growth arrest-specific protein 6;
ZIKV, Zika virus.
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from ZIKV infection.67 However, no antiviral activity
was detected when ZIKV-infected cells were treated
with IFNl1,67 indicating that ZIKV may antagonize
IFNl1 signaling. A study on human dendritic cells
showed that ZIKV induced strong upregulation of type
I interferon (IFN) transcript but appeared to inhibit
translation of the IFN protein, although other antiviral
proteins were upregulated.68
Other studies revealed specific roles ZIKV NS proteins
play in disrupting host immune defense, by targeting
components of the JAK/STAT pathway, presumably
depleting the host defenses. STAT1 and STAT2
are some of the transcriptional regulators of IFN
responses.69 ZIKV NS5 selectively binds to STAT2,
resulting in proteosomal degradation of this protein in
human cells but not in mice, presumably inhibiting type
I IFN signaling.70,71 In addition, NS5 expression
enhanced STAT1-STAT1 homodimers and their recruit-
ment to IFN-g-stimulated genes such as pro-inflamma-
tory cytokine CXCL10.72 A novel STAT2/ mouse
model showed particular vulnerability to ZIKV infection
and recapitulated viral dissemination to the CNS,
gonads, and other visceral organs, and displayed neuro-
logical symptoms73 similar to those suspected to be asso-
ciated with the virus in human subjects. Intriguingly,
human STAT2 mutations, although rare, predispose
patients to multiorgan failure, including neurological
deterioration, following viral infection.74 NS1 and
NS4B proteins inhibit IFNb signaling by targeting
TBK1 (TANK-binding kinase 1 level)75 which is required
for phosphorylation of IFN regulatory factor 3 to initiate
type I IFN transcriptions.76 ZIKV NS2B-NS3 are
involved in proteosomal-directed degradation of janus
kinase I.75 Interestingly, NS1, NS4B, and NS2B-NS3
cooperate to enhance ZIKV infection by blocking IFN-
induced autophagic degradation of NS2B-NS3.75 These
putative roles by ZIKV may limit neurogenesis, by inter-
fering with growth of neural cell precursors (as described
below).
ZIKV-Induced Placental Injury and
Influence on Fetal Brain Development
The human placenta, a transient organ, provides protec-
tion against viruses by acting as a physical barrier and
offering innate and adaptive immune defenses, during in
utero development. Therefore, viral-induced changes in
placental physiologies may inflict lasting injury to the
fetal nervous system. Detection of ZIKV particles and
mRNA in the placental tissue, amniotic fluid, and corres-
ponding fetal brain tissues12,77–79 suggests transplacental
passage by the virus. Human placentation requires inva-
sion of the maternal decidua basalis (decidua) by tropho-
blasts of the blastocyst. The 2 main interfaces are the
decidua that serves as the anchoring point for the
placenta and the intervillous space where maternal
blood is in contact with placental villi.80–82 Placental
villi are covered by a superficial multinuclear syncytiotro-
phoblast (STB) layer, which overlaid an inner mono-
nuclear cytotrophoblast (CTB) layer. At the base of the
anchoring villi, proliferative CTBs differentiate into
extravillous trophoblasts, grow into the decidua, and
remodel uterine arteries to facilitate blood flow into the
intervillous space.80–82 Placental invasion by viruses may
occur via direct and contiguous infection of the cellular
layers, virion passage through a breach, or by cell-
mediated transport. However, it is not clear precisely
which of these mechanisms is used by ZIKV.
Nevertheless, fetal vulnerability to ZIKV during early
development is presumed to be a result of first trimester
primary trophoblast expression of AXL and other entry
receptors.83 It has been speculated that primary tropho-
blasts may express AXL prior to differentiation into
CTBs and STBs.83
ZIKV infection of placental chorionic villi tissues
resulted in increased expression of IFNa, IFNb, and
IFNl (but not IFNg) and the upregulation of transcripts
associated with apoptosis, cell death, and necrosis.84 Cell
death either by apoptosis or necrosis leads to the cata-
strophic destruction of placental architecture. Viral
destruction of developmental and placental vasculature
by ZIKV can also result in fetal brain injury.12,85
Upon infection of the placental cells, ZIKV not only
suppresses the innate and adaptive immune responses82
but may also proceed to induce the production of inflam-
matory cytokines and trigger the upregulation of genes
involved in apoptosis and necrosis. Analyses of human
placental tissues obtained from pregnant women showed
chronic inflammatory lesions 1 week after ZIKV infec-
tion in the first trimester, and examination of correspond-
ing brain tissues revealed microcalcification and viral
proteins and particles in glial cells.12 Viral-induced
production of pro-inflammatory cytokines, such as
IL-1b, IL-6, and TNF-a, can alter the intra-amniotic
milieu and impact fetal brain development.
Intrauterine inflammation during pregnancy can lead to
premature births, which are associated with a number of
neurodevelopmental disorders.86 In vitro studies not
involving viral-induced secretion of pro-inflammatory
cytokines by placenta showed that IL-1b and
TNF-a decrease the proliferation of NPCs derived
from animal models.87–89 In mice, IL-1a, another pro-
inflammatory cytokine, induces the differentiation of
astrocytes from NPCs.88 ZIKV may limit neurogenesis
by inducing NPCs differentiating into astrocyte lineage
in mice,90 although it is not clear if this is dependent
on IL-1a.
ZIKV-induced disruption of placental function can
either delay or inhibit the secretion of developmental
growth factors by this organ, potentially resulting in
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fetal brain injury. A number of studies showed that
placental-derived developmental factors are important
for neurocortical development,91–94 a principal neural
target of ZIKV. Disruption of the levels of these factors
can potentially lead to anomalies observed in infected
infants derived from viral-infected pregnancies. Viral
infection of the placenta is capable of inducing changes
in fetal brain morphology, which are associated with an
inflammatory condition in both fetal brain and fetal tis-
sues, despite the lack of viral infection in the fetal tissue
itself.95,96
ZIKV-associated maternal inflammation may also
inhibit placental or gestational growth factors and subse-
quently affect neural development. Induction of maternal
inflammation alters the course of neurodevelopment,
which can influence the behavior of offsprings.97,98
Maternal inflammation resulted in deregulated produc-
tion of placental-derived 5-HT, leading to neurodevelop-
mental defects,99 as evident by the disruption of neuronal
proliferation and axonal outgrowth.100 In addition, viral-
induced inflammation of the placenta and decidua can
alter the fetal immune system, resulting in poor postnatal
immune responses to vaccines or infections that affect the
nervous system.96,101,102 ZIKV-induced placental and
maternal inflammation may be underlying mechanisms
that resulted in postnatal restricted brain growth follow-
ing normal preserved head circumference at birth.
However, the precise mechanism(s) by which ZIKV
limit placental physiology leading to restricted neural
growth is not completely understood.
Gross Neuroanatomical Changes
Imaging analyses revealed a number of gross neuroana-
tomical aberrations in ZIKV-associated congenital
microcephaly. Some brains showed hypoplastic cerebellar
vermis with hypoplastic cerebellar hemispheres and
brainstem hypertrophy.103 The corpus callosum, which
is important for communication between the 2 cerebral
hemispheres, appeared thin, dysgenetic, and hypoplastic
or in some cases completely absent.103 Calcification
appears widespread as well. Calcium deposits were
detected in the thalamus, basal ganglia, cortex, and peri-
ventricular regions,103 and this may be associated with
seizure and epilepsy reported for some cases of ZIKV-
associated microcephaly.104,105 Thinner cerebral
cortex,1,14,106 reduced gyration and loss of white and
gray matter contents, and ventriculomegaly—enlarged
brain ventricles—103,107,108 were detected (Figure 2).
Autopsy and postmortem studies on fetuses and infants
derived from ZIKV-infected pregnancies also revealed
similar neurological anomalies.109 Studies of neuro-
spheres and brain organoids grown from human NPCs
(hNPCs) showed that ZIKV infection resulted in
restricted growth of these structures.110,111 Although the
severity of neuroanatomical malformations are greater
Figure 2. Sketches comparing a normal brain of a 5-month-old infant to that of an age-matched ZIKV-associated microcephaly brain.
Lateral view (upper row) shows reduced gyration in ZIKV-associated microcephaly brain compared to that of a normal infant. Transverse
sections (lower row) revealed calcium deposits (white spots), enlarge ventricles (asterisks), and reduced brain volume in ZIKV-associated
microcephaly brain compared to a normal brain. Gray areas are where normal brain tissue grow. Dark areas are presumed to be fluid filled
spaces, including the ventricles. ZIKV, Zika virus.
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during ZIKV infection at first trimester, ZIKV infection
at 36th week (third trimester) of pregnancy can still result
in fetal brain injury, characterized by subependymal cysts
and lenticulostriate vasculopathy in an otherwise normal-
sized brain.112 ZIKV-associated brain architecture may
also arise from viral-induced neuroinflammatory pro-
cesses such as diffuse microglial hyperplasia and severe
astrocyte hypertrophy, macrophage, lymphocyte, and
leukocyte infiltration1,12,113–115 and release of inflamma-
tory cytokines by infected neuronal cells.
ZIKV-Associated Molecular
Neurocytopathy
Subcellular derangement arising from ZIKV infection of
neurons may be related to changes in the expression of
genes and proteins related to the cell cycle, stress
response, cell death, intracellular structural organization,
cell differentiation, innate and adaptive immune
responses, cell proliferations, cell migration, cell adhe-
sion, and synaptic organization.111,116–119 Notable intra-
cellular changes resulting from ZIKV infection of
neurons include aberrant granulation pattern in the cyto-
plasm, irregular cell shape, partial nuclear condensation,
pyknosis or ‘‘vacuolar nuclei’’ appearance, swollen mito-
chondria, disorganized ER architecture, and super-
numerary mitotic spindle.37,115,118,120,121 ZIKV-induced
cytoplasmic vacuolization has been demonstrated in
astrocytes, among other cell types.66 Sec61 translocon-
dependent formation of large vacuoles from the ER and
telltale signs of paraptosis-like cell death were detected in
ZIKV-infected astrocytes.66 This effect is amplified when
IFITM protein levels are low.66
ZIKV-infected hNPCs also showed significant
reorganization of intermediate filament and microtubule
networks and remodeling of the cytoskeleton,122 perhaps
to favor viral replication. Moreover, ZIKV-infected neu-
rons showed supernumerary foci with centriolar proteins,
supernumerary centrosomes, and impaired mitotic spin-
dle positioning.121,123 Some of these changes are consist-
ent with viral infection of cells and subcellular changes
associated with congenital brain malformation (eg,
microcephaly). A recent study using fission yeast for
genome-wide analysis of ZIKV proteins attributed intra-
cellular changes to specific ZIKV proteins. All 14 struc-
tural and nonstructural ZIKV proteins and peptides were
expressed under an inducible promoter in fission yeast
and their intracellular localization and cytopathic activ-
ities subsequently determined.124 The authors found that
membrane-anchored capsid (anaC), C, prM, M, E,
NS2B, and NS4A caused elongation of cells, while cellu-
lar hypotrophy was a consequence of prM, NS2B, and
NS4A124 (Table 1).
ZIKV-induced intracellular structural disorganization
may also be related to the deregulation of genes involved
in microcephaly. Molecular genetic analyses identified
mutations in at least 12 genes mapped to the microceph-
aly (MCPH) loci. Most of these genes are expressed by
NPCs where they play important roles in mitotic orien-
tation and positioning and centrosomal integrity, and
their mutant variants are associated with severe brain
malformation, including microcephaly (reviewed in
Faheem et al.128). Gene expression studies of embryonic
and fetal brain samples of ZIKV-infected mice and
ZIKV-infected NPCs revealed the downregulation of sev-
eral MCPH genes, including those that code for centro-
somal proteins (Table 2).116,117 Microcephalin, a
centrosomal protein (MCPH1) with a DNA repair func-
tions, regulates G2/M checkpoint transition.129 RNA
depletion and mutation of MCHP1 resulted in premature
onset of chromosome condensation, and this may lead to
delayed mitosis.130,131 Reduced expression of MCPH1
increases the production of early born neurons, which
are located in deep layers (IV–VI), and reduces the late-
born neurons, which produce the thinner outer cortex
layer (II–III) (reviewed in Faheem et al.128).132,133 The
CASC5 protein attaches the kinetochore to microtubules
of the mitotic apparatus, ensuring correct segregation of
chromosomes.134 Mutated CASC5 resulted in mitotic
arrest and reduced brain volume.134–136 The deregulation
of CENPJ/CPAP, which is important for centrosome sta-
bility and duplication,137,138 resulted in the randomiza-
tion of the cell’s division plane.139,140 CENPJ/CPAP
deletion resulted in the formation of multiple spindle
poles, apoptosis, and mitotic arrest.141 Loss of
CDK5RAP2 resulted in switching from symmetric pro-
liferative divisions to asymmetric divisions of
NPCs.139,142 Cerebral organoids generated from human
cells harboring a truncated CDK5RAP2, while smaller
and containing fewer NPCs, also showed aberrant cell
polarity.143 These examples underscore the importance
of centrosomal proteins in neurogenesis; therefore, the
deregulation of their expression by viral infection can
produce severe brain malformation.
Potential ZIKV-induced downregulation of MCPH
genes may be related to viral microRNAs (miRNAs) or
short noncoding RNAs that target these said genes.
miRNAs are short (21–25 nucleotides) fragments of
RNAs that are partially complementary to mRNAs. By
hybridizing to the mRNA, an miRNA is able to down-
regulate or silent the expression of a specific gene post-
transcriptionally. Computational modeling analyses
revealed a number of ZIKV miRNAs that can target
human MCPH genes.144,145 However, experimental evi-
dence is needed to further elucidate the precise role(s) of
ZIKV in the deregulation of MCPH genes leading to
microcephaly. Such investigations may involve the use
of ZIKV-derived miRNAs to inhibit the expression of
specific MCPH gene and study the changes in embryonic,
fetal, and neonatal brains in animal models.
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Disruption of Cell Cycle Progression of
Neuronal Precursors
During forebrain development, NPCs proliferate, differ-
entiate in diverse neuronal cell fates, and migrate to their
final position in the cortical plate, where they mature into
adult neurons. The temporal and spatial precisions with
which these processes occur during telencephalic develop-
ment are important for higher order functions including
language, emotion, and cognition. Therefore, eradication
of NPCs during telencephalic development can lead to
severe neurodevelopmental problems including primary
congenital microcephaly.166–168 As indicated, ZIKV-
induced upregulation of TLR3 in NPCs is associated
with the deregulation of genes involved in neurogenesis,
including those that regulate cell cycle progression.110
Following ZIKV infection of NPCs, G1 phase regulatory
proteins including cyclin D1 (CCND1), cyclin-dependent
kinase (CDK4), and E2F1, E2F3, and JUN transcription
factors were downregulated, whereas cyclin-dependent
kinase inhibitor 2A (CDKN2A/p16) and a CCND1
inhibitor were upregulated.119 These alterations may rep-
resent an underlying mechanism that resulted in
decreased M phase NPC population116 and the accumu-
lation of sub-G1 phase cycle in ZIKV-infected neuro-
spheres grown from NPCs.111 The specific roles of
ZIKV proteins in cell cycle delay have been demonstrated
Table 1. Molecular and Cytopathic Effects of Zika Virus Proteins.
Proteins Molecular and Cytopathic Effects Study
anaC Cell elongation (fission yeast) Li et al.124
Cell cycle G1 accumulation (fission yeast)
C Cell elongation (fission yeast) Li et al.124
prM Cellular hypotrophy (fission yeast) Li et al.124
Cell cycle G1 accumulation (fission yeast) Li et al.124
M Cell elongation (fission yeast) Li et al.124
Cell cycle G2/M accumulation (fission yeast)
E Cell elongation (fission yeast) Li et al.124
Cell cycle G2/M accumulation
NS2B Complexes with NS3 for proteosomal-directed JAK1 degradation (A549 cells) Wu et al.75
and Li et al.124
N2B cooperates with NS1, NS4B and NS3 to block IFN-induced autophagic degradation
of NS2B-NS3 complex to enhance viral replication (A549 cells)
Wu et al.75
Cellular hypotrophy (fission yeast) Li et al.124
NS1 NS1 cooperates with NS4B and NS2B-NS3 to block IFN-induced autophagic-degradation
of NS2B-NS3 (A549 cells)
Wu et al.75
NS1 together with NS4B inhibit IFNb signaling by targeting TBK1 (TANK-binding kinase
1 level)
Wu et al.75
NS2A Reduces mouse radial glia proliferation and differentiation; degrades adhesion junction
proteins (mouse developing cortex)
Yoon et al.125
NS3 Cooperate with NS1, NS4B and NS2 to block IFN-induced autophatic-associated
degradation of NS2B-NS3 complex to enhance viral replication (A549 cells)
Wu et al.75
NS4A Cellular hypotrophy (yeast fission) Li et al.124
Cell cycle G2/M accumulation (fission yeast) Li et al.124
Together with NS4B inhibit Akt-mTOR signaling and induce autophagy, limiting
neurogenesis (human fetal neural stem cells)
Li et al.124
NS4B NS4B together with NS1 inhibit IFNb signaling by targeting TBK1 (TANK-binding kinase
1 level) (A549 cells)
Wu et al.75
Together with NS4A inhibit Akt-mTOR signaling and induce autophagy, limiting
neurogenesis (human fetal neural stem cells)
Liang et al.126
NS5 NS5 targets the IFN-regulated transcriptional activator STAT2 for proteosomal
degradation, inhibiting IFN signaling (293T cells).
Grant et al.71
NS5 enhances STAT1-STAT1 homodimers and their recruitment to IFN-g-stimulated
genes such as pro-inflammatory (JEG3 choriocarcinoma and SF268 glioblastoma cells)
Chaudhary et al.127
Abbreviations: anaC, membrane-anchored capsid; C, capsid protein; E, envelope protein; IFN, interferon; M, membrane protein; prM, premembrane protein.
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in fission yeast.124 The expression of ZIKV prM protein
resulted in cell cycle G1 accumulation, whereas the
expression of proteins encoded by anaC, M, E, and
NS4A lead to cell cycle G2/M accumulation.124 Of indir-
ect relevance, Li et al.116 showed decreased M phase
NPCs in ZIKV-infected neurospheres, whereas Li
et al.124 indicated the accumulation of G2/M phase
accumulation cells. This discrepancy may be explained
on the basis of differences in expression systems used.
Neuronal Cell Death
As indicated, ZIKV can induce cell death by apoptosis
and by autophagy.14,117,119 ZIKV-induced apoptosis is
Table 2. Microcephaly Genes That Are Potentially Deregulated in ZIKV-Associated Fetal and Pediatric Neuropathologies.
Gene Symbol Gene Name Protein Function
Putative Cellular Effects/Defects on Brain
Development
CDK5RAP2 CDK5 regulatory subunit-
associated protein 2
Centrosomal protein localizes to
centrosome during mitosis142
CDK5RAP2 mutation reduces the progenitor
pool, thereby decreasing the number of
neurons, reduces cell survival146–148
MCPH1 Microcephalin Chromosomal condensation,
G2/M checkpoint regulator129
Reduced MCPH1 enhances the production of
early born neurons, which comprise deep
layers (IV–VI), and reduces the late-born





chore to microtubule of
mitotic apparatus, chromo-
some segregation134
Defects in CASC5 may result in decreased
volume of the human brain134–136
WDR62 WD repeat-containing
protein 62
Localizes to the nucleus and
centrosome, regulate mitosis
progression in NPCs149,150
Neurocortical development, proliferation and
migration of neuronal precursors, WDR62
mutations affect its role in proliferating and
migrating NPCs, delay mitotic progression, and




Regulates orientation of mitotic
spindle in NPCs, symmetric
divisions in neuroepithelial
cells154,155
ASPM mutations alter orientation of mitotic
spindle, reducing the size of the brain156,157
CENPJ/CPAP Centromere protein J Important for centrosome
integrity and spindle
morphology139,140
CENJP deletion causes an increased incidence of




Regulates mitotic spindle check-
point and apoptosis158
STIL mutation is lethal to zebrafish embryos, and
STIL knockout mice (Sil/) exhibit numerous
developmental abnormalities/decreased size/
defective midline neural tube158–160




CEP135 knockdown resulted in restricted growth
rate/disorganized microtubules159,161,162
ZNF335 Zinc finger protein 335 Controls neural progenitor self-
renewal, neurogenesis, and
neuronal differentiation163
Mutated ZNF335 gene causes degeneration of
neurons, knockdown of ZNF335 caused a
small brain size with an absent cortex/






Mutated PHC1-associated chromatin remodeling
is suspected in pathogenesis of primary
mycophagy164
CDK6 Cyclin-dependent kinase 6 Associates with centrosome
during mitosis and regulates
centrosome number, organ-
izes microtubules165
CDK6 mutation affects apical neuronal precursor
cells proliferation/reduces progenitor pool/
decreases neuronal production/primary
microcephaly165
Abbreviation: NPCs, neural progenitor cells.
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evident by abnormal morphological changes in infected
neurons (as described).1,12 In addition, ZIKV infections
resulted in increased caspase-3 (CASP3) activities in
in vitro and in vivo models; in proliferative, immature
(eg, NPCs) and mature neurons; and in human neuroepi-
thelial stem cells.14,15,116,119–121 The activation of CASP3
may be a result of ZIKV suppression of cellular immune
response. Cells of the anterior subventricular zone (SVZ)
of the forebrain and subgranular zone of the hippocam-
pal dentate gyrus of ZIKV-infected mice, deficient in IFN
response factor, showed elevated CASP3 activities.169
Moreover, ZIKV induced cell death by autophagy in
hNPCs generated from induced PSCs, neurospheres
raised from NPCs, and in vivo studies using SJL
mice.14,116,117,119 It is presumed that after infecting the
NPCs of the fetal brain, ZIKV nonstructural proteins
NS4A and NS4B suppressed the P13K-Akt-mTOR path-
way, resulting in autophagy and inhibiting neurogenesis
(Table 2).126,170,171 Although apoptosis and autophagy
can be independent mechanisms of cell death, ZIKV
infection can affect the expression of genes involved in
both processes. Studies showed that ZIKV neurotropism
resulted in the upregulation of Bmf, DAPK3, Irgm1,
PKD Bcl2, Htt, CASP3, Caspa, MIL1, ATG2, ATG3,
ATG9, Abl1, ATF4, ULK1, AMBRA1, IRE1, and
TNFRSF1 and the suppression of CASP2, CASP6,
GADD45a, VPS34, Fasl, ATG12, Bcl2l11, Dffa, and
ATF6.14,116,117,119 Finally, ZIKV-induced translocation
of the centrosomal protein phosphor-TBK1 to the mito-
chondria of human neuroepithelial stem cells and radial
glial (RG) cells, lead to cell death, among other cellular
effects.121 Examination of postmortem forebrain of
ZIKV-associated microcephaly revealed massive death
of cells that correspond to NPCs.121 Some of these
events involved in ZIKV-associated microcephaly
mirror those linked to mutational and heredity micro-
cephaly. Mice and humans with mutations in centroso-
mal genes exhibit deficits including supernumerary
centrosomes and failed cytokinesis, resulting in severely
defective neurogenesis, extensive apoptosis in the prolif-
erative zones, and microcephaly.172–175
ZIKV-induced inflammation may also drive the death
of NPCs, via paracrine mode. During early development,
cranial neural crest cells (CNCCs) that form the cranial
bones exert paracrine effects on the developing brain. An
in vitro study showed that ZIKV-infected CNCCs,
although resistant to apoptosis, secrete significant levels
of cytokines that resulted death NPCs.176
Inhibition of Neuronal Migration
Defects in neuronal migration have been linked to con-
genital microcephaly.177 Studies indicated that ZIKV
infection is associated with the inhibition of neural
migration, and perhaps leading to ZIKV-associated
microcephaly. As indicated, ZIKV infects RGs,121
which are also important for the development of the
CNS.178 RGs are housed deep within the embryonic
and fetal brain from where they project radial fibers to
the pia surface of the cortex.179 The radial fibers form
tissue scaffold that guide migrating newborn neurons to
their correct positions in the cortical plate. RGs also act
as neural stem cell pools, with the potential to differenti-
ate into diverse neuronal and glial cell types, including
neurons, oligodentrocytes, and astrocytes. Therefore,
eradication of RGs (eg, by viral infections) can lead to
severe developmental defects and limited cortical forma-
tion. ZIKV particles have been detected in the RGs of
infected mice brains.116 ZIKV infection of RGs might be
facilitated by the expression of the putative ZIKV candi-
date receptor AXL in the cortex, with very strong expres-
sion bordering the lateral ventricle and the outer SVZ,180
a region where RGs are known to reside in humans.181
A recent study showed that ZIKV NS2A protein reduced
proliferation of RGs and also degrade adherent junction
(AJ) proteins in mouse cerebral cortex and human fore-
brain organoids.125 ZIKV-associated loss of AJ can result
in aberrant glial scaffold and misdirected neurons.
At the molecular level, ZIKV infections resulted in the
downregulation of genes that code for proteins involved
in neuronal migration (as well as neuronal maturation
and differentiation).116 Among these genes are those
that code for (Jun, JunB, Egr2, and KLF4) transcription
factors116 that regulate the expression of gap junction
proteins, connexins—Cx43 and Cx26.182–185 Connexins
have been implicated in neuronal migration.183,186 Cx43
and Cx26 proteins accumulate at the point where migrat-
ing neurons contact RG fibers.186 Loss of Cx43 expres-
sion resulted in reduced neuronal migration, thereby
disrupting brain development,187–189 a feature consistent
with migration defects.
Inhibition of neuronal migration may be related to
ZIKV-associated deregulation of the MCPH protein,
WDR62. WDR62 protein is expressed by NPCs as well
as by postmitotic neurons of the developing brain
and localizes to the spindle poles of dividing cells
(Table 2).149,150 Mutations in the WDR62 protein or
depletion of its mRNA have been linked to defects in
neuronal migration.151,153
Although much of the forgoing discussion indicated
NPCs are principal ZIKV targets, the heterogenous
gene expression and the lack of normal 3D brain archi-
tecture generated from NPCs raised from iPSCs or
embryonic stem cells to model ZIKV brain infection
prompted a search for other ZIKV neurocellular targets.
A recent study using fetal brain slices obtained from the
second trimester gestational period suggested that inter-
mediate progenitor cells (IPCs) and committed postmito-
tic cells are the main neurocellular targets of ZIKV in the
fetal brain.190 Although IPCs are located mainly in the
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SVZ, they undergo limited mitotic division191–194 and
their eradication can still lead to deficits in cortical for-
mation. However, the study by Lin et al.190 suffers from a
lack of first trimester brain samples, a time when the fetal
brain is most susceptible to ZIKV infection. Therefore, it
is possible that first trimester NPCs are principal cellular
targets of ZIKV insults.
In summary, cell death, neuronal migration defects,
and misdirected and reduced proliferation associated
with ZIKV infection of NPCs, can lead to the formation
of a thinner cortex of the developing forebrain (Figure 3).
ZIKV-Associated Congenital
Ocular Anomalies
A number of clinical studies have reported ocular anoma-
lies, specifically in the retina and choroid, of infants with
congenital ZIKV infection.195–199 ZIKV invasion of oph-
thalmic tissues resulted in adverse illnesses, which include
optic neutitis, chorioretinal atrophy, circumscribed
pigment, iris colobomas, and lens subluxation, and blind-
ness in neonates, and conjunctivitis and uveitis in
adults,56,200 have been reported. In addition, AXL
expression has been observed in the outer margin of the
neural retina and in cells of the ciliary marginal zone
adjacent to neural retina,180,201 suggesting a possible
underlying mechanism for macular atrophy (leading to
blindness) in babies born to ZIKV-infected mothers. In
IFNRA1 knockout (IFNRAI/) mice, ZIKV infection
was found in the optic nerve, retina, iris, and cornea, and
also triggered panuveittis, conjunctivitis, and neuroretini-
tis.56 In addition, retinal neurons appeared to be targeted
by ZIKV and this was associated with infections in the
lateral geniculate, suprachiasmatic nuclei, and superior
colliculus,202 indicating a potential for the virus to
infect cells along the visual pathway. This selective infec-
tion may be due to axonal transport of viral particles.202
ZIKV can also disturb the retinal vasculature. ZIKV
targets retinal endothelial cells, retinal pericytes, and ret-
inal pigmented epithelial cells of the blood-retinal barrier,
Figure 3. During the formation of the neural cortex, neural progenitors are generated in the SVZ from where they migrate along radial
glial fibers to the pia surface. The cortex develops in an ‘‘inside-out’’ manner. First-born neurons differentiate and occupy layers VI and V,
and those produced later, will reside in layers IV, III, II, and I. In this manner, layer I is the last to form. It is presumed that ZIKV-induced
depletion of NPCs resulted in a thinner neural cortex-associated microcephaly.
SVZ, subventricular zone; ZIKV, Zika virus.
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where its replicates productively and stimulates
the expression of the inflammatory cytokine,
RANTES,203,204 potentially disrupting the permeability
of the retinal vasculature, and resulting in chorioretinal
atrophy.203 These data, taken together, suggest that
ZIKV may produce eye diseases, leading to blindness in
newborns arising from infected pregnancies.
Conclusion
Accelerated laboratory research has now confirmed
that ZIKV is a potential teratogenic agent, associated
with increased incidences of primary/congenital and
progressive microcephaly, among other associated neuro-
developmental disorders. The virus targets the neural
stem cell pools, deregulating genes involved in cell
death, proliferation, differentiation, and migration.
ZIKV-induced disruption of neurogenesis may lead to
the formation of thinner forebrain cortex. To inflict its
catastrophic effects on brain development, ZIKV must
first traverse the placental barrier. In vitro and
in vivo evidence indicate that ZIKV infection comprom-
ises placental integrity, more so during the first trimester.
In addition, ZIKV-induced placental-derived inflamma-
tory cytokines may also contribute to the demise of
NPCs, in utero.
A major challenge in ZIKV research is to determine
the precise mechanism(s) of cellular invasion. A good
measure of studies identified several putative ZIKV
entry receptors. AXL expression has been reported for
both placenta and fetal brain tissues, and this correlates
well with ZIKV neuropathological effects. However,
some studies showed that ZIKV infection occurs in the
absence of AXL expression, indicating that other uniden-
tified receptors might mediate viral infections. Receptor-
independent mechanisms including exosomes and ECVs
and TNTs for viral dissemination are also possible. The
use of exosomes and TNTs for spreading viral infection
allows viruses to escape immune detection and eradica-
tion. Whether ZIKV tropism uses a receptor-independent
mechanism remains a question for further debate
and research. However, it is hopeful that current and
future research endeavors will help to elucidate the pre-
cise mechanism(s) of ZIKV neuropathologies, with the
hope of providing effective treatment and developing
measures to limit the dissemination of the virus in
infected hosts.
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect
to the research, authorship, and/or publication of this article.
Funding
The author(s) received no financial support for the research, author-
ship, and/or publication of this article.
References
1. Driggers RW, Ho CY, Korhonen EM, et al. Zika virus infec-
tion with prolonged maternal viremia and fetal brain abnorm-
alities. N Engl J Med. 2016;374(22):2142–2151.
2. Macnamara FN. Zika virus: a report on three cases of human
infection during an epidemic of jaundice in Nigeria. Trans R
Soc Trop Med Hyg. 1954;48(2):139–145.
3. Bearcroft WG. Zika virus infection experimentally induced in
a human volunteer. Trans R Soc Trop Med Hyg. 1956;
50(5):442–448.
4. Simpson DI. Zika virus infection in man. Trans R Soc Trop
Med Hyg. 1964;58:335–338.
5. Duffy MR, Chen TH, Hancock WT, et al. Zika virus outbreak
on Yap Island, Federated States of Micronesia. N Engl J Med.
2009;360(24):2536–2543.
6. Heymann DL, Hodgson A, Sall AA, et al. Zika virus and
microcephaly: why is this situation a PHEIC? Lancet. 2016;
387(10020):719–721.
7. Baronti C, Piorkowski G, Charrel RN, Boubis L, Leparc-
Goffart I, de Lamballerie X. Complete coding sequence of
Zika virus from a French polynesia outbreak in 2013.
Genome Announc. 2014;2(3):e00500–e00514.
8. Hayes EB. Zika virus outside Africa. Emerg Infect Dis. 2009;
15(9):1347–1350.
9. Foy BD, Kobylinski KC, Chilson Foy JL. Probable non-vector-
borne transmission of Zika virus, Colorado, USA. Emerg Infect
Dis. 2011;17(5):880–882.
10. Calvet G, Aguiar RS, Melo AS, et al. Detection and sequencing
of Zika virus from amniotic fluid of fetuses with microcephaly
in Brazil: a case study. Lancet Infect Dis. 2016;16(6):653–660.
11. Musso D, Nhan T, Robin E, et al. Potential for Zika virus
transmission through blood transfusion demonstrated during
an outbreak in French Polynesia, November 2013 to
February 2014. Euro Surveill. 2014;19(14):20761.
12. Noronha L, Zanluca C, Azevedo ML, Luz KG, Santos CN.
Zika virus damages the human placental barrier and presents
marked fetal neurotropism. Mem Inst Oswaldo Cruz. 2016;
111(5):287–293.
13. Bhatnagar J, Rabeneck DB, Martines RB, et al. Zika virus
RNA replication and persistence in brain and placental
tissue. Emerg Infect Dis. 2017;23(3):405–414.
14. Cugola FR, Fernandes IR, Russo FB, et al. The Brazilian Zika
virus strain causes birth defects in experimental models.
Nature. 2016;534(7606):267–271.
15. Miner JJ, Cao B, Govero J, et al. Zika virus infection during
pregnancy in mice causes placental damage and fetal demise.
Cell. 2016;165(5):1081–1091.
16. Nguyen HN, Qian X, Song H, Ming GL. Neural stem cells
attacked by Zika virus. Cell Res. 2016;26(7):753–754.
17. Valentine G, Marquez L, Pammi M. Zika virus-associated
microcephaly and eye lesions in the newborn. J Pediatr
Infect Dis Soc. 2016;5(3):323–328.
18. Chang C, Ortiz K, Ansari A, Gershwin ME. The Zika outbreak
of the 21st century. J Autoimmun. 2016;68:1–13.
19. Tian H, Ji X, Yang X, et al. The crystal structure of Zika virus
helicase: basis for antiviral drug design. Protein Cell. 2016;
7(6):450–454.
20. Aman MJ, Kashanchi F. Zika virus: a new animal model for an
arbovirus. PLoS Negl Trop Dis. 2016;10(5):e0004702.
Gharbaran and Somenarain 11
21. Lazear HM, Diamond MS. Zika virus: new clinical syndromes
and its emergence in the Western Hemisphere. J Virol. 2016;
90(10):4864–4875.
22. Mukhopadhyay S, Kuhn RJ, Rossmann MG. A structural per-
spective of the flavivirus life cycle. Nat Rev Microbiol. 2005;
3(1):13–22.
23. Faye O, Freire CC, Iamarino A, et al. Molecular evolution of
Zika virus during its emergence in the 20(th) century. PLoS
Negl Trop Dis. 2014;8(1):e2636.
24. Chambers TJ, Hahn CS, Galler R, Rice CM. Flavivirus genome
organization, expression, and replication. Annu Rev Microbiol.
1990;44:649–688.
25. Haddow AD, Nasar F, Guzman H, et al. Genetic characteriza-
tion of Spondweni and Zika viruses and susceptibility of geo-
graphically distinct strains of Aedes aegypti, Aedes albopictus
and Culex quinquefasciatus (Diptera: Culicidae) to Spondweni
virus. PLoS Negl Trop Dis. 2016;10(10):e0005083.
26. Kuno G, Chang GJ. Full-length sequencing and genomic char-
acterization of Bagaza, Kedougou, and Zika viruses. Arch
Virol. 2007;152(4):687–696.
27. Wang L, Valderramos SG, Wu A, et al. From mosquitos to
humans: genetic evolution of Zika virus. Cell Host Microbe.
2016;19(5):561–565.
28. Faria NR, Azevedo Rdo S, Kraemer MU, et al. Zika virus in
the Americas: early epidemiological and genetic findings.
Science. 2016;352(6283):345–349.
29. Yokoyama S, Starmer WT. Possible roles of new mutations
shared by Asian and American Zika viruses. Mol Biol Evol.
2017;34(3):525–534.
30. Lucchese G, Kanduc D. Zika virus and autoimmunity: from
microcephaly to Guillain-Barre syndrome, and beyond.
Autoimmun Rev. 2016;15(8):801–808.
31. Lanciotti RS, Kosoy OL, Laven JJ, et al. Genetic and serologic
properties of Zika virus associated with an epidemic, Yap
State, Micronesia, 2007. Emerg Infect Dis. 2008;
14(8):1232–1239.
32. Barba-Spaeth G, Dejnirattisai W, Rouvinski A, et al. Structural
basis of potent Zika-dengue virus antibody cross-neutraliza-
tion. Nature. 2016;536(7614):48–53.
33. Pierson TC, Graham BS. Zika virus: immunity and vaccine
development. Cell. 2016;167(3):625–631.
34. Dejnirattisai W, Supasa P, Wongwiwat W, et al. Dengue virus
sero-cross-reactivity drives antibody-dependent enhancement
of infection with Zika virus. Nat Immunol. 2016;
17(9):1102–1108.
35. Priyamvada L, Quicke KM, Hudson WH, et al. Human anti-
body responses after dengue virus infection are highly cross-
reactive to Zika virus. Proc Natl Acad Sci U S A. 2016;
113(28):7852–7857.
36. Perera-Lecoin M, Meertens L, Carnec X, Amara A. Flavivirus
entry receptors: an update. Viruses. 2013;6(1):69–88.
37. Hamel R, Dejarnac O, Wichit S, et al. Biology of Zika virus
infection in human skin cells. J Virol. 2015;89(17):8880–8896.
38. Pujhari S, Macias VM, Nissly RH, Nomura M, Kuchipudi SV,
Rasgon J. Heat shock protein 70 (Hsp70) is involved in the
Zika virus cellular infection process. https://www.biorxiv.org/
content/early/2017/05/08/135350. Published 2017. Accessed
July 9, 2018.
39. Lemke G. Biology of the TAM receptors. Cold Spring Harb
Perspect Biol. 2013;5(11):a009076.
40. Fourgeaud L, Traves PG, Tufail Y, et al. TAM receptors regu-
late multiple features of microglial physiology. Nature. 2016;
532(7598):240–244.
41. Johnson K, Ji R. TAM receptors: two pathways to regulate
adult neurogenesis. Neural Regen Res. 2015;10(3):344–345.
42. Ji R, Meng L, Jiang X, et al. TAM receptors support neural
stem cell survival, proliferation and neuronal differentiation.
PLoS One. 2014;9(12):e115140.
43. Wang J, Zhang H, Young AG, et al. Transcriptome analysis of
neural progenitor cells by a genetic dual reporter strategy. Stem
Cells. 2011;29(10):1589–1600.
44. Olagnier D, Muscolini M, Coyne CB, Diamond MS, Hiscott J.
Mechanisms of Zika virus infection and neuropathogenesis.
DNA Cell Biol. 2016;35(8):367–372.
45. Stitt TN, Conn G, Gore M, et al. The anticoagulation factor
protein S and its relative, Gas6, are ligands for the Tyro 3/Axl
family of receptor tyrosine kinases. Cell. 1995;80(4):661–670.
46. Richard AS, Shim BS, Kwon YC, et al. AXL-dependent infec-
tion of human fetal endothelial cells distinguishes Zika virus
from other pathogenic flaviviruses. Proc Natl Acad Sci U S A.
2017;114(8):2024–2029.
47. Funakoshi H, Yonemasu T, Nakano T, Matumoto K,
Nakamura T. Identification of Gas6, a putative ligand for
Sky and Axl receptor tyrosine kinases, as a novel neurotrophic
factor for hippocampal neurons. J Neurosci Res. 2002;
68(2):150–160.
48. Yagami T, Ueda K, Asakura K, et al. Gas6 rescues cortical
neurons from amyloid beta protein-induced apoptosis.
Neuropharmacology. 2002;43(8):1289–1296.
49. Shankar SL, O’Guin K, Cammer M, et al. The growth arrest-
specific gene product Gas6 promotes the survival of human
oligodendrocytes via a phosphatidylinositol 3-kinase-depen-
dent pathway. J Neurosci. 2003;23(10):4208–4218.
50. Shankar SL, O’Guin K, Kim M, et al. Gas6/Axl signaling acti-
vates the phosphatidylinositol 3-kinase/Akt1 survival pathway
to protect oligodendrocytes from tumor necrosis factor alpha-
induced apoptosis. J Neurosci. 2006;26(21):5638–5648.
51. Sainaghi PP, Collimedaglia L, Alciato F, et al. Elevation of
Gas6 protein concentration in cerebrospinal fluid of patients
with chronic inflammatory demyelinating polyneuropathy
(CIDP). J Neurol Sci. 2008;269(1–2):138–142.
52. Prieto AL, Weber JL, Tracy S, Heeb MJ, Lai C. Gas6, a ligand
for the receptor protein-tyrosine kinase Tyro-3, is widely
expressed in the central nervous system. Brain Res. 1999;
816(2):646–661.
53. Wang C, Jin H, Wang N, et al. Gas6/Axl axis contributes
to chemoresistance and metastasis in breast cancer through
Akt/GSK-3beta/beta-catenin signaling. Theranostics. 2016;
6(8):1205–1219.
54. Wu G, Ma Z, Hu W, et al. Molecular insights of Gas6/TAM in
cancer development and therapy. Cell Death Dis. 2017;
8(3):e2700.
55. Wells MF, Salick MR, Wiskow O, et al. Genetic ablation of
AXL does not protect human neural progenitor cells and cere-
bral organoids from Zika virus infection. Cell Stem Cell. 2016;
19(6):703–708.
56. Miner JJ, Sene A, Richner JM, et al. Zika virus infection in
mice causes panuveitis with shedding of virus in tears. Cell
Rep. 2016;16(12):3208–3218.
12 Pediatric and Developmental Pathology 0(0)
57. Hastings AK, Yockey LJ, Jagger BW, et al. TAM receptors are
not required for Zika virus infection in mice. Cell Rep. 2017;
19(3):558–568.
58. Narayanan A, Iordanskiy S, Das R, et al. Exosomes derived
from HIV-1-infected cells contain trans-activation response
element RNA. J Biol Chem. 2013;288(27):20014–20033.
59. Ramakrishnaiah V, Thumann C, Fofana I, et al. Exosome-
mediated transmission of hepatitis C virus between human
hepatoma Huh7.5 cells. Proc Natl Acad Sci U S A. 2013;
110(32):13109–13113.
60. Jaworski E, Narayanan A, Van Duyne R, et al. Human T-lym-
photropic virus type 1-infected cells secrete exosomes that con-
tain tax protein. J Biol Chem. 2014;289(32):22284–22305.
61. Zhu X, He Z, Yuan J, et al. IFITM3-containing exosome as a
novel mediator for anti-viral response in dengue virus infec-
tion. Cell Microbiol. 2015;17(1):105–118.
62. Sowinski S, Jolly C, Berninghausen O, et al. Membrane nano-
tubes physically connect T cells over long distances presenting
a novel route for HIV-1 transmission. Nat Cell Biol. 2008;
10(2):211–219.
63. Roberts KL, Manicassamy B, Lamb RA. Influenza A virus
uses intercellular connections to spread to neighboring cells.
J Virol. 2015;89(3):1537–1549.
64. Brass AL, Huang IC, Benita Y, et al. The IFITM proteins
mediate cellular resistance to influenza A H1N1 virus, West
Nile virus, and dengue virus. Cell. 2009;139(7):1243–1254.
65. Savidis G, Perreira JM, Portmann JM, et al. The IFITMs inhibit
Zika virus replication. Cell Rep. 2016;15(11):2323–2330.
66. Monel B, Compton AA, Bruel T, et al. Zika virus induces
massive cytoplasmic vacuolization and paraptosis-like death
in infected cells. EMBO J. 2017;36(12):1653–1668.
67. Bayer A, Lennemann NJ, Ouyang Y, et al. Type III interferons
produced by human placental trophoblasts confer protection
against Zika virus infection. Cell Host Microbe. 2016;
19(5):705–712.
68. Bowen JR, Quicke KM, Maddur MS, et al. Zika virus antag-
onizes type I interferon responses during infection of human
dendritic cells. PLoS Pathog. 2017;13(2):e1006164.
69. Au-Yeung N, Mandhana R, Horvath CM. Transcriptional regu-
lation by STAT1 and STAT2 in the interferon JAK-STAT
pathway. JAKSTAT. 2013;2(3):e23931.
70. Kumar A, Hou S, Airo AM, et al. Zika virus inhibits type-I
interferon production and downstream signaling. EMBO Rep.
2016;17(12):1766–1775.
71. Grant A, Ponia SS, Tripathi S, et al. Zika virus targets human
STAT2 to inhibit type I interferon signaling. Cell Host
Microbe. 2016;19(6):882–890.
72. Chaudhary V, Yuen KS, Chan JF, et al. Selective activation of
type II interferon signaling by Zika virus NS5 protein. J Virol.
2017;91(14):e00163–17.
73. Tripathi S, Balasubramaniam VR, Brown JA, et al. A novel
Zika virus mouse model reveals strain specific differences in
virus pathogenesis and host inflammatory immune responses.
PLoS Pathog. 2017;13(3):e1006258.
74. Shahni R, Cale CM, Anderson G, et al. Signal transducer and
activator of transcription 2 deficiency is a novel disorder of
mitochondrial fission. Brain. 2015;138(Pt 10):2834–2846.
75. Wu Y, Liu Q, Zhou J, et al. Zika virus evades interferon-
mediated antiviral response through the co-operation of mul-
tiple nonstructural proteins in vitro. Cell Discov. 2017;3:17006.
76. Liu S, Cai X, Wu J, et al. Phosphorylation of innate immune
adaptor proteins MAVS, STING, and TRIF induces IRF3 acti-
vation. Science. 2015;347(6227):aaa2630.
77. Martines RB, Bhatnagar J, Keating MK, et al. Notes from the
field: evidence of Zika virus infection in brain and placental
tissues from two congenitally infected newborns and two fetal
losses—Brazil, 2015. MMWR Morb Mortal Wkly Rep. 2016;
65(6):159–160.
78. Calvet G, Aguiar RS, Melo AS, et al. Detection and sequencing
of Zika virus from amniotic fluid of fetuses with microcephaly
in Brazil: a case study. Lancet Infect Dis. 2016;16(6):653–660.
79. Mlakar J, Korva M, Tul N, et al. Zika virus associated with
microcephaly. N Engl J Med. 2016;374(10):951–958.
80. Smith SK. Angiogenesis and implantation. Hum Reprod. 2000;
15 Suppl 6:59–66.
81. Jabrane-Ferrat N, Siewiera J. The up side of decidual natural
killer cells: new developments in immunology of pregnancy.
Immunology. 2014;141(4):490–497.
82. El Costa H, Gouilly J, Mansuy JM, et al. Zika virus reveals
broad tissue and cell tropism during the first trimester of preg-
nancy. Sci Rep. 2016;6:35296.
83. Aagaard KM, Lahon A, Suter MA, et al. Primary human pla-
cental trophoblasts are permissive for Zika virus (ZIKV) rep-
lication. Sci Rep. 2017;7:41389.
84. Weisblum Y, Oiknine-Djian E, Vorontsov OM, et al. Zika
virus infects early- and midgestation human maternal decidual
tissues, inducing distinct innate tissue responses in the mater-
nal-fetal interface. J Virol. 2017;91(4):e01905–16.
85. Shao Q, Herrlinger S, Yang SL, et al. Zika virus infection
disrupts neurovascular development and results in postnatal
microcephaly with brain damage. Development. 2016;
143(22):4127–4136.
86. Elovitz MA, Brown AG, Breen K, et al. Intrauterine inflam-
mation, insufficient to induce parturition, still evokes fetal and
neonatal brain injury. Int J Dev Neurosci. 2011;29(6):663–671.
87. Wang X, Fu S, Wang Y, et al. Interleukin-1beta mediates pro-
liferation and differentiation of multipotent neural precursor
cells through the activation of SAPK/JNK pathway. Mol Cell
Neurosci. 2007;36(3):343–354.
88. Ajmone-Cat MA, Cacci E, Ragazzoni Y, Minghetti L, Biagioni
S. Pro-gliogenic effect of IL-1alpha in the differentiation of
embryonic neural precursor cells in vitro. J Neurochem.
2010;113(4):1060–1072.
89. Cacci E, Claasen JH, Kokaia Z. Microglia-derived tumor
necrosis factor-alpha exaggerates death of newborn hippocam-
pal progenitor cells in vitro. J Neurosci Res. 2005;
80(6):789–797.
90. Lossia OV, Conway MJ, Tree MO, et al. Zika virus induces
astrocyte differentiation in neural stem cells. J Neurovirol.
2017;24(1):52–61.
91. Nicol MB, Hirst JJ, Walker D. Effects of pregnanolone on
behavioural parameters and the responses to GABA(A) recep-
tor antagonists in the late gestation fetal sheep.
Neuropharmacology. 1999;38(1):49–63.
92. Petraglia F, Imperatore A, Challis JR. Neuroendocrine mech-
anisms in pregnancy and parturition. Endocr Rev. 2010;
31(6):783–816.
93. Montiel JF, Kaune H, Maliqueo M. Maternal-fetal unit inter-
actions and eutherian neocortical development and evolution.
Front Neuroanat. 2013;7:22.
Gharbaran and Somenarain 13
94. Fietz SA, Lachmann R, Brandl H, et al. Transcriptomes of
germinal zones of human and mouse fetal neocortex suggest a
role of extracellular matrix in progenitor self-renewal. Proc
Natl Acad Sci U S A. 2012;109(29):11836–11841.
95. Cardenas I, Means RE, Aldo P, et al. Viral infection of the
placenta leads to fetal inflammation and sensitization to bac-
terial products predisposing to preterm labor. J Immunol.
2010;185(2):1248–1257.
96. Mor G. Placental inflammatory response to Zika virus may
affect fetal brain development. Am J Reprod Immunol. 2016;
75(4):421–422.
97. Patterson PH. Maternal infection: window on neuroimmune
interactions in fetal brain development and mental illness.
Curr Opin Neurobiol. 2002;12(1):115–118.
98. Wang X, Stridh L, Li W, et al. Lipopolysaccharide sensitizes
neonatal hypoxic-ischemic brain injury in a MyD88-depen-
dent manner. J Immunol. 2009;183(11):7471–7477.
99. Goeden N, Velasquez J, Arnold KA, et al. Maternal inflam-
mation disrupts fetal neurodevelopment via increased placen-
tal output of serotonin to the fetal brain. J Neurosci. 2016;
36(22):6041–6049.
100. Bonnin A, Torii M, Wang L, Rakic P, Levitt P. Serotonin
modulates the response of embryonic thalamocortical axons
to netrin-1. Nat Neurosci. 2007;10(5):588–597.
101. Racicot K, Kwon JY, Aldo P, Silasi M, Mor G. Understanding
the complexity of the immune system during pregnancy. Am J
Reprod Immunol. 2014;72(2):107–116.
102. Silasi M, Cardenas I, Kwon JY, Racicot K, Aldo P, Mor G.
Viral infections during pregnancy. Am J Reprod Immunol.
2015;73(3):199–213.
103. Soares de Oliveira-Szejnfeld P, Levine D, Melo AS, et al.
Congenital brain abnormalities and Zika virus: what the radi-
ologist can expect to see prenatally and postnatally.
Radiology. 2016;281(1):203–218.
104. Asadi-Pooya AA. Zika virus-associated seizures. Seizure.
2016;43:13.
105. Pessoa A, van der Linden V, Yeargin-Allsopp M, et al. Motor
abnormalities and epilepsy in infants and children with evi-
dence of congenital Zika virus infection. Pediatrics. 2018;
141(Suppl 2): S167–S179.
106. Li C, Xu D, Ye Q, et al. Zika virus disrupts neural progenitor
development and leads to microcephaly in mice. Cell Stem
Cell. 2016;19(5):672.
107. Culjat M, Darling SE, Nerurkar VR, et al. Clinical and ima-
ging findings in an infant with Zika embryopathy. Clin Infect
Dis. 2016;63(6):805–811.
108. Hazin AN, Poretti A, Turchi Martelli CM, et al. Computed
tomographic findings in microcephaly associated with Zika
virus. N Engl J Med. 2016;374(22):2193–2195.
109. Schwartz DA. Autopsy and postmortem studies are concord-
ant: pathology of Zika virus infection is neurotropic in fetuses
and infants with microcephaly following transplacental trans-
mission. Arch Pathol Lab Med. 2017;141(1):68–72.
110. Dang J, Tiwari SK, Lichinchi G, et al. Zika virus depletes
neural progenitors in human cerebral organoids through acti-
vation of the innate immune receptor TLR3. Cell Stem Cell.
2016;19(2):258–265.
111. Garcez PP, Loiola EC, Madeiro da Costa R, et al. Zika virus
impairs growth in human neurospheres and brain organoids.
Science. 2016;352(6287):816–818.
112. Soares de Souza A, Moraes Dias C, Braga FD, et al. Fetal
infection by zika virus in the third trimester: report of 2 cases.
Clin Infect Dis. 2016;63(12):1622–1625.
113. Bell TM, Field EJ, Narang HK. Zika virus infection of the
central nervous system of mice. Arch Gesamte Virusforsch.
1971;35(2):183–193.
114. Aliota MT, Caine EA, Walker EC, Larkin KE, Camacho E,
Osorio JE. Characterization of lethal Zika virus infection in
AG129 mice. PLoS Negl Trop Dis. 2016;10(4):e0004682.
115. Dowall SD, Graham VA, Rayner E, et al. A susceptible
mouse model for Zika virus infection. PLoS Negl Trop Dis.
2016;10(5):e0004658.
116. Li C, Xu D, Ye Q, et al. Zika virus disrupts neural progenitor
development and leads to microcephaly in mice. Cell Stem
Cell. 2016;19(1):120–126.
117. Wu KY, Zuo GL, Li XF, et al. Vertical transmission of Zika
virus targeting the radial glial cells affects cortex develop-
ment of offspring mice. Cell Res. 2016;26(6):645–654.
118. Garcez PP, Nascimento JM, de Vasconcelos JM, et al. Zika
virus disrupts molecular fingerprinting of human neuro-
spheres. Sci Rep. 2017;7:40780.
119. Tang H, Hammack C, Ogden SC, et al. Zika virus infects
human cortical neural progenitors and attenuates their
growth. Cell Stem Cell. 2016;18(5):587–590.
120. Hanners NW, Eitson JL, Usui N, et al. Western Zika virus in
human fetal neural progenitors persists long term with partial
cytopathic and limited immunogenic effects. Cell Rep. 2016;
15(11):2315–2322.
121. Onorati M, Li Z, Liu F, et al. Zika virus disrupts phospho-
TBK1 localization and mitosis in human neuroepithelial stem
cells and radial glia. Cell Rep. 2016;16(10):2576–2592.
122. Cortese M, Goellner S, Acosta EG, et al. Ultrastructural char-
acterization of Zika virus replication factories. Cell Rep.
2017;18(9):2113–2123.
123. Wolf B, Diop F, Ferraris P, et al. Zika virus causes super-
numerary foci with centriolar proteins and impaired spindle
positioning. Open Biol. 2017;7(1):160231.
124. Li G, Poulsen M, Fenyvuesvolgyi C, et al. Characterization of
cytopathic factors through genome-wide analysis of the Zika
viral proteins in fission yeast. Proc Natl Acad Sci U S A.
2017;114(3):E376–E385.
125. Yoon KJ, Song G, Qian X, et al. Zika-virus-encoded NS2A
disrupts mammalian cortical neurogenesis by degrading
adherens junction proteins. Cell Stem Cell. 2017;
21(3):349–358.e6.
126. Liang Q, Luo Z, Zeng J, et al. Zika virus NS4A and NS4B
proteins deregulate Akt-mTOR signaling in human fetal
neural stem cells to inhibit neurogenesis and induce autop-
hagy. Cell Stem Cell. 2016;19(5):663–671.
127. Chaudhary V, Yuen KS, Chan JF, et al. Selective activation of
interferon-gamma signaling by Zika virus NS5 protein.
J Virol. 2017;91(14):e00163–17.
128. Faheem M, Naseer MI, Rasool M, et al. Molecular genetics of
human primary microcephaly: an overview. BMC Med
Genomics. 2015; 8 Suppl 1:S4.
129. Alderton GK, Galbiati L, Griffith E, et al. Regulation of
mitotic entry by microcephalin and its overlap with ATR
signalling. Nat Cell Biol. 2006;8(7):725–733.
130. Neitzel H, Neumann LM, Schindler D, et al. Premature
chromosome condensation in humans associated with
14 Pediatric and Developmental Pathology 0(0)
microcephaly and mental retardation: a novel autosomal reces-
sive condition. Am J Hum Genet. 2002;70(4):1015–1022.
131. Trimborn M, Schindler D, Neitzel H, Hirano T. Misregulated
chromosome condensation in MCPH1 primary
microcephaly is mediated by condensin II. Cell Cycle.
2006;5(3):322–326.
132. Cox J, Jackson AP, Bond J, Woods CG. What primary micro-
cephaly can tell us about brain growth. Trends Mol Med.
2006;12(8):358–366.
133. Zhou ZW, Tapias A, Bruhn C, Gruber R, Sukchev M, Wang
ZQ. DNA damage response in microcephaly development of
MCPH1 mouse model. DNA Repair (Amst). 2013;
12(8):645–655.
134. Kiyomitsu T, Obuse C, Yanagida M. Human Blinkin/
AF15q14 is required for chromosome alignment and the mito-
tic checkpoint through direct interaction with Bub1 and
BubR1. Dev Cell. 2007;13(5):663–676.
135. Cheeseman IM, Hori T, Fukagawa T, Desai A. KNL1 and the
CENP-H/I/K complex coordinately direct kinetochore assem-
bly in vertebrates. Mol Biol Cell. 2008;19(2):587–594.
136. Saadi A, Verny F, Siquier-Pernet K, et al. Refining the pheno-
type associated with CASC5 mutation. Neurogenetics. 2016;
17(1):71–78.
137. Cottee MA, Muschalik N, Wong YL, et al. Crystal structures
of the CPAP/STIL complex reveal its role in centriole assem-
bly and human microcephaly. Elife. 2013;2:e01071.
138. Vulprecht J, David A, Tibelius A, et al. STIL is required
for centriole duplication in human cells. J Cell Sci. 2012;
125(Pt 5):1353–1362.
139. Bond J, Roberts E, Springell K, et al. A centrosomal mech-
anism involving CDK5RAP2 and CENPJ controls brain size.
Nat Genet. 2005;37(4):353–355.
140. Garcez PP, Diaz-Alonso J, Crespo-Enriquez I, Castro D, Bell
D, Guillemot F. Cenpj/CPAP regulates progenitor divisions
and neuronal migration in the cerebral cortex downstream of
Ascl1. Nat Commun. 2015;6:6474.
141. Koyanagi M, Hijikata M, Watashi K, et al. Centrosomal P4.1-
associated protein is a new member of transcriptional coacti-
vators for nuclear factor-kappaB. J Biol Chem. 2005;
280(13):12430–12437.
142. Lizarraga SB, Margossian SP, Harris MH, et al. Cdk5rap2
regulates centrosome function and chromosome segregation
in neuronal progenitors. Development. 2010;
137(11):1907–1917.
143. Lancaster MA, Renner M, Martin CA, et al. Cerebral orga-
noids model human brain development and microcephaly.
Nature. 2013;501(7467):373–379.
144. McLean E, Bhattarai R, Hughes BW, Mahalingam K, Bagasra
O. Computational identification of mutually homologous Zika
virus miRNAs that target microcephaly genes. Libyan J Med.
2017;12(1):1304505.
145. Pylro VS, Oliveira FS, Morais DK, et al. ZIKV—CDB: a
collaborative database to guide research linking SncRNAs
and Zika virus disease symptoms. PLoS Negl Trop Dis.
2016;10(6):e0004817.
146. Issa L, Kraemer N, Rickert CH, et al. CDK5RAP2 expression
during murine and human brain development correlates with
pathology in primary autosomal recessive microcephaly.
Cereb Cortex. 2013;23(9):2245–2260.
147. Zhang X, Liu D, Lv S, et al. CDK5RAP2 is required for
spindle checkpoint function. Cell Cycle. 2009;
8(8):1206–1216.
148. Fong KW, Choi YK, Rattner JB, Qi RZ. CDK5RAP2 is a
pericentriolar protein that functions in centrosomal attach-
ment of the gamma-tubulin ring complex. Mol Biol Cell.
2008;19(1):115–125.
149. Nicholas AK, Khurshid M, Desir J, et al. WDR62 is asso-
ciated with the spindle pole and is mutated in human micro-
cephaly. Nat Genet. 2010;42(11):1010–1014.
150. Chen JF, Zhang Y, Wilde J, Hansen KC, Lai F, Niswander L.
Microcephaly disease gene Wdr62 regulates mitotic progres-
sion of embryonic neural stem cells and brain size. Nat
Commun. 2014;5:3885.
151. Yu TW, Mochida GH, Tischfield DJ, et al. Mutations in
WDR62, encoding a centrosome-associated protein, cause
microcephaly with simplified gyri and abnormal cortical
architecture. Nat Genet. 2010;42(11):1015–1020.
152. Bilguvar K, Ozturk AK, Louvi A, et al. Whole-exome sequen-
cing identifies recessive WDR62 mutations in severe brain
malformations. Nature. 2010;467(7312):207–210.
153. Xu D, Zhang F, Wang Y, Sun Y, Xu Z. Microcephaly-asso-
ciated protein WDR62 regulates neurogenesis through JNK1
in the developing neocortex. Cell Rep. 2014;6(6):1176–1177.
154. Kouprina N, Pavlicek A, Collins NK, et al. The microcephaly
ASPM gene is expressed in proliferating tissues and encodes
for a mitotic spindle protein. Hum Mol Genet. 2005;
14(15):2155–2165.
155. Fish JL, Kosodo Y, Enard W, Paabo S, Huttner WB. ASPM
specifically maintains symmetric proliferative divisions of
neuroepithelial cells. Proc Natl Acad Sci U S A. 2006;
103(27):10438–10443.
156. Bond J, Roberts E, Mochida GH, et al. ASPM is a major
determinant of cerebral cortical size. Nat Genet. 2002;
32(2):316–320.
157. do Carmo Avides M, Glover DM. Abnormal spindle protein,
Asp, and the integrity of mitotic centrosomal microtubule
organizing centers. Science. 1999;283(5408):1733–1735.
158. Pfaff KL, Straub CT, Chiang K, Bear DM, Zhou Y, Zon LI.
The zebra fish cassiopeia mutant reveals that SIL is required
for mitotic spindle organization. Mol Cell Biol. 2007;
27(16):5887–5897.
159. Ohta T, Essner R, Ryu JH, Palazzo RE, Uetake Y, Kuriyama
R. Characterization of Cep135, a novel coiled-coil centroso-
mal protein involved in microtubule organization in mamma-
lian cells. J Cell Biol. 2002;156(1):87–99.
160. Kumar A, Girimaji SC, Duvvari MR, Blanton SH. Mutations
in STIL, encoding a pericentriolar and centrosomal protein,
cause primary microcephaly. Am J Hum Genet. 2009;
84(2):286–290.
161. Hussain MS, Baig SM, Neumann S, et al. A truncating muta-
tion of CEP135 causes primary microcephaly and disturbed
centrosomal function. Am J Hum Genet. 2012;90(5):871–878.
162. Campaner S, Kaldis P, Izraeli S, Kirsch IR. Sil phosphoryl-
ation in a Pin1 binding domain affects the duration of the
spindle checkpoint. Mol Cell Biol. 2005;25(15):6660–6672.
163. Yang YJ, Baltus AE, Mathew RS, et al. Microcephaly
gene links trithorax and REST/NRSF to control neural stem
cell proliferation and differentiation. Cell. 2012;
151(5):1097–1112.
Gharbaran and Somenarain 15
164. Awad S, Al-Dosari MS, Al-Yacoub N, et al. Mutation in PHC1
implicates chromatin remodeling in primary microcephaly
pathogenesis. Hum Mol Genet. 2013;22(11):2200–2213.
165. Hussain MS, Baig SM, Neumann S, et al. CDK6 associates
with the centrosome during mitosis and is mutated in a large
Pakistani family with primary microcephaly. Hum Mol Genet.
2013;22(25):5199–5214.
166. Barkovich AJ, Guerrini R, Kuzniecky RI, Jackson GD,
Dobyns WB. A developmental and genetic classification for
malformations of cortical development: update 2012. Brain.
2012;135(Pt 5):1348–1369.
167. Wilsch-Brauninger M, Florio M, Huttner WB. Neocortex
expansion in development and evolution—from cell biology
to single genes. Curr Opin Neurobiol. 2016;39:122–132.
168. Robinson S. Systemic prenatal insults disrupt telencephalon
development: implications for potential interventions.
Epilepsy Behav. 2005;7(3):345–363.
169. Li H, Saucedo-Cuevas L, Regla-Nava JA, et al. Zika virus
infects neural progenitors in the adult mouse brain and alters
proliferation. Cell Stem Cell. 2016;19(5):593–598.
170. Lee DY. Roles of mTOR signaling in brain development. Exp
Neurobiol. 2015;24(3):177–185.
171. Takei N, Nawa H. mTOR signaling and its roles in normal
and abnormal brain development. Front Mol Neurosci. 2014;
7:28.
172. Diaz AL, Gleeson JG. The molecular and genetic mechanisms
of neocortex development. Clin Perinatol. 2009;
36(3):503–512.
173. Woods CG. Human microcephaly. Curr Opin Neurobiol.
2004;14(1):112–117.
174. Roberts MR, Bittman K, Li WW, et al. The flathead mutation
causes CNS-specific developmental abnormalities and apop-
tosis. J Neurosci. 2000;20(6):2295–2306.
175. Bae BI, Jayaraman D, Walsh CA. Genetic changes shaping
the human brain. Dev Cell. 2015;32(4):423–434.
176. Bayless NL, Greenberg RS, Swigut T, Wysocka J, Blish CA,
et al. Zika virus infection induces cranial neural crest cells to
produce cytokines at levels detrimental for neurogenesis. Cell
Host Microbe. 2016;20(4):423–428.
177. Liu JS. Molecular genetics of neuronal migration disorders.
Curr Neurol Neurosci Rep. 2011;11(2):171–178.
178. Howard BM, Zhicheng M, Filipovic R, Moore AR, Antic SD,
Zecevic N. Radial glia cells in the developing human brain.
Neuroscientist. 2008;14(5):459–473.
179. Bentivoglio M, Mazzarello P. The history of radial glia. Brain
Res Bull. 1999;49(5):305–315.
180. Nowakowski TJ, Pollen AA, Di Lullo E, Sandoval-Espinosa
C, Bershteyn M, Kriegstein AR. Expression analysis high-
lights AXL as a candidate Zika virus entry receptor in
neural stem cells. Cell Stem Cell. 2016;18(5):591–596.
181. Hansen DV, Lui JH, Parker PR, Kriegstein AR. Neurogenic
radial glia in the outer subventricular zone of human neocor-
tex. Nature. 2010;464(7288):554–561.
182. Dermietzel R, Traub O, Hwang TK, et al. Differential expres-
sion of three gap junction proteins in developing and mature
brain tissues. Proc Natl Acad Sci U S A. 1989;
86(24):10148–10152.
183. Matsuuchi L, Naus CC. Gap junction proteins on the move:
connexins, the cytoskeleton and migration. Biochim Biophys
Acta. 2013;1828(1):94–108.
184. Yamamoto T, Vukelic J, Hertzberg EL, Nagy JI. Differential
anatomical and cellular patterns of connexin43 expression
during postnatal development of rat brain. Brain Res Dev
Brain Res. 1992;66(2):165–180.
185. Cina C, Bechberger JF, Ozog MA, Naus CC. Expression of
connexins in embryonic mouse neocortical development.
J Comp Neurol. 2007;504(3):298–313.
186. Elias LA, Wang DD, Kriegstein AR. Gap junction adhesion is
necessary for radial migration in the neocortex. Nature. 2007;
448(7156):901–907.
187. Nadarajah B, Jones AM, Evans WH, Parnavelas JG.
Differential expression of connexins during neocortical devel-
opment and neuronal circuit formation. J Neurosci. 1997;
17(9):3096–3111.
188. Liu X, Hashimoto-Torii K, Torii M, Ding C, Rakic P. Gap
junctions/hemichannels modulate interkinetic nuclear migra-
tion in the forebrain precursors. J Neurosci. 2010;
30(12):4197–4209.
189. Fushiki S, Perez Velazquez JL, Zhang L, Bechberger JF,
Carlen PL, Naus CC. Changes in neuronal migration in neo-
cortex of connexin43 null mutant mice. J Neuropathol Exp
Neurol. 2003;62(3):304–314.
190. Lin MY, Wang YL, Wu WL, et al. Zika virus infects inter-
mediate progenitor cells and post-mitotic committed neurons
in human fetal brain tissues. Sci Rep. 2017;7(1):14883.
191. Pontious A, Kowalczyk T, Englund C, Hevner RF. Role of
intermediate progenitor cells in cerebral cortex development.
Dev Neurosci. 2008;30(1–3):24–32.
192. Haubensak W, Attardo A, Denk W, Huttner WB. Neurons
arise in the basal neuroepithelium of the early mammalian
telencephalon: a major site of neurogenesis. Proc Natl Acad
Sci U S A. 2004;101(9):3196–3201.
193. Miyata T, Kawaguchi A, Saito K, Kawano M, Muto T,
Ogawa M. Asymmetric production of surface-dividing and
non-surface-dividing cortical progenitor cells. Development.
2004;131(13):3133–3145.
194. Noctor SC, Martinez-Cerdeno V, Ivic L, Kriegstein AR.
Cortical neurons arise in symmetric and asymmetric division
zones and migrate through specific phases. Nat Neurosci.
2004;7(2):136–144.
195. Miranda HA II, Costa MC, Frazao MA, Simao N,
Franchischini S, Moshfeghi DM. Expanded spectrum of con-
genital ocular findings in microcephaly with presumed Zika
infection. Ophthalmology. 2016;123(8):1788–1794.
196. de Paula Freitas B, de Oliveira Dias JR, Prazeres J, et al.
Ocular findings in infants with microcephaly associated
with presumed Zika virus congenital infection in Salvador,
Brazil. JAMA Ophthalmol. 2016;134(5):529–535.
197. Ventura CV, Maia M, Bravo-Filho V, Gois AL, Belfort R Jr.
Zika virus in Brazil and macular atrophy in a child with
microcephaly. Lancet. 2016;387(10015):228.
198. Ventura CV, Maia M, Dias N, Ventura LO, Belfort R Jr. Zika:
neurological and ocular findings in infant without microceph-
aly. Lancet. 2016;387(10037):2502.
199. de Oliveira Dias JR, Ventura CV, Borba PD, et al. Infants
with congenital Zika syndrome and ocular findings from Sao
Paulo, Brazil: spread of infection [published online ahead of
print January 2, 2017]. Retin Cases Brief Rep. doi:10.1097/
ICB.0000000000000518.
16 Pediatric and Developmental Pathology 0(0)
200. Sun J, Wu D, Zhong H. Presence of Zika virus in conjunctival
fluid. JAMA Ophthalmol. 2016;134(11):1330–1332.
201. McCarthy M. Severe eye damage in infants with microceph-
aly is presumed to be due to Zika virus. Br Med J. 2016;352:
i855.
202. van den Pol AN, Mao G, Yang Y, et al. Zika virus targeting in
the developing brain. J Neurosci. 2017;37(8):2161–2175.
203. Singh PK, Guest JM, Kanwar M, et al. Zika virus infects cells
lining the blood-retinal barrier and causes chorioretinal atro-
phy in mouse eyes. JCI Insight. 2017;2(4):e92340.
204. Salinas S, Erkilic N, Damodar K, et al. Zika virus efficiently
replicates in human retinal epithelium and disturbs its perme-
ability. J Virol. 2017;91(3):e02144–16.
Gharbaran and Somenarain 17
